Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009636
Filing Date
2020-08-06
Accepted
2020-08-06 16:03:48
Documents
73
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20200630x10q.htm   iXBRL 10-Q 2009819
2 EX-10.1 ardx-20200630xex10d1.htm EX-10.1 22671
3 EX-10.2 ardx-20200630xex10d2.htm EX-10.2 65153
4 EX-10.3 ardx-20200630xex10d3.htm EX-10.3 23423
5 EX-10.4 ardx-20200630xex10d4.htm EX-10.4 66985
6 EX-10.5 ardx-20200630xex10d5.htm EX-10.5 379136
7 EX-31.1 ardx-20200630xex31d1.htm EX-31.1 15500
8 EX-31.2 ardx-20200630xex31d2.htm EX-31.2 15506
9 EX-32.1 ardx-20200630xex32d1.htm EX-32.1 12005
10 GRAPHIC ardx-20200630xex10d1001.jpg GRAPHIC 5706
11 GRAPHIC ardx-20200630xex10d3001.jpg GRAPHIC 5706
  Complete submission text file 0001558370-20-009636.txt   7445209

Data Files

Seq Description Document Type Size
12 EX-101.SCH ardx-20200630.xsd EX-101.SCH 49389
13 EX-101.CAL ardx-20200630_cal.xml EX-101.CAL 52892
14 EX-101.DEF ardx-20200630_def.xml EX-101.DEF 151957
15 EX-101.LAB ardx-20200630_lab.xml EX-101.LAB 366633
16 EX-101.PRE ardx-20200630_pre.xml EX-101.PRE 295838
17 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20200630x10q_htm.xml XML 1166496
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 201081507
SIC: 2834 Pharmaceutical Preparations